Clinical Trial Update: Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind study evaluating pregabalin for pancreatic cancer pain; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Parc de Salut Mar | Conditions: Pancreatic Cancer, Visceral Pain | Phase 4 | Status: TERMINATED